Invest in the future of Medicinal Cannabis with the NHS 

EIS Advance Assurance from HMRC 

Why Invest?

On 1 November 2018 the law changed to allow doctors on the General Medical Council’s Specialist Register to prescribe unlicensed cannabis-based products for medicinal use (CBPM), where it is clinically appropriate and in the best interest of patients. 

Already working with NHS and NIHR to provide proof of concept for a patent pending prescription technology platform.

Medicinal Cannabis is available on the NHS if:

Your child has one of the rare forms of epilepsy that might be helped by medical cannabis


Learn More

We will have a UK Network of ‘Best Practice’ medical centres where specialists can prescribe or oversee prescriptions of Medicinal Cannabis. 

Annual predicted net profit over sales metric of  ‘plus 43%’

Medicaleaf™ intends to generate revenue in excess of £5.34 million in this first trading year. 

Medicaleaf™ will have a ‘post-raise’ valuation of £20 million with expectations to reach a pre-floatation valuation of £200 million in three years’ time. 

 Offset over 50% of your investment with CGT and EIS relief.

You have spasticity from MS and treatments for this aren't helping

You suffer from vomiting or feel sick from chemotherapy 

A legal route now exists to prescribe and supply CBPMs in the UK, where it is clinically appropriate to do so! 

UK Government Response to Health and Social Care Select Commitee report



Disclaimer: The information provided on this website is for information purposes only. The website and its content are not, and should not be deemed to be an offer of, or invitation to engage in any investment activity. The website should not be construed as advice, or a personal recommendation by Medicaleaf Ltd . Medicaleaf Ltd  is not authorised and regulated by the Financial Conduct Authority (FCA). The content of this promotion is not authorised under the Financial Services and Markets Act 2000 (FSMA). Reliance on the promotion for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the investment. UK residents wishing to participate in this promotion must fall into the category of sophisticated investor or high net worth individual as outlined by the Financial Conduct Authority (FCA).

With up to 30% UK Tax Relief

Earn 43% returns per annum